Lightpoint Medical, a UK-based company which develops surgical imaging technologies, raised £2m ($3.1 m) in a Series A funding round.
Investors included Oxford Technology and angel networks Cambridge Capital Group, London Business Angels, Envestors, Ruffena Capital and crowdfunding platform SyndicateRoom.
The company intends to use the funds to bring its two lead products LightPath™ and EnLight™ to the US and European markets in 2015.
Led by Dr David Tuch, CEO, Lightpoint Medical is a developer of innovative surgical imaging technologies for surgeons to detect cancer in real-time during surgery and reduce the need for repeat operations. The company has clinical trials underway in breast, prostate, and stomach cancer.